Tag Archives: medicine


Contrary to modern popular perception, in games and such, a good part of Wizardry (real Wizardry) is healing and medicine. The Wizard shares that in common with the ancient Monk and Hermit.

The Wizard is engrossed with Life (Bios) and how it actually works. As much, if not more so, than with physics and chemistry and other such fundamental sciences.

The Wizard should seek first to know God, and then he should seek to understand Life, God’s Ultimate Creation.


Our Ancient and Medieval ancestors were much, much more ingenious that most modern people give them credit for. Someone should create/produce an app/algorithm to scour ancient and medieval medicinal texts (and other kinds of texts) to see what other advantages could be gleaned.

Rather than doing this kind of work (and this is hardly the first example I’ve seen of such historical re-creation) by piecemeal examination and experimentation.

By the way I not long ago finished another set of brilliant lectures by Mike Drought of Wheaton College.

Take cropleek and garlic, of both equal quantities, pound them well together… take wine and bullocks gall, mix with the leek… let it stand nine days in the brass vessel…

So goes a thousand-year-old Anglo Saxon recipe to vanquish a stye, an infected eyelash follicle.

The medieval medics might have been on to something. A modern-day recreation of this remedy seems to alleviate infections caused by the bacteria that are usually responsible for styes. The work might ultimately help create drugs for hard-to-treat skin infections.

The project was born when a microbiologist at the University of Nottingham, UK, got talking to an Anglo Saxon scholar. They decided to test a recipe from an Old English medical compendium called Bald’s Leechbook, housed in the British Library.

Some of the ingredients, such as copper from the brass vessel, kill bacteria grown in a dish – but it was unknown if they would work on a real infection or how they would combine.

Careful collection

Sourcing authentic ingredients was a major challenge, says Freya Harrison, the microbiologist. They had to hope for the best with the leeks and garlic because modern crop varieties are likely to be quite different to ancient ones – even those branded as heritage. For the wine they used an organic vintage from a historic English vineyard.

As “brass vessels” would be hard to sterilise – and expensive – they used glass bottles with squares of brass sheet immersed in the mixture. Bullocks gall was easy, though, as cow’s bile salts are sold as a supplement for people who have had their gall bladders removed.

After nine days of stewing, the potion had killed all the soil bacteria introduced by the leek and garlic. “It was self-sterilising,” says Harrison. “That was the first inkling that this crazy idea just might have some use.”

A side effect was that it made the lab smell of garlic. “It was not unpleasant,” says Harrison. “It’s all edible stuff. Everyone thought we were making lunch.”

The potion was tested on scraps of skin taken from mice infected with methicillin-resistant Staphylococcus aureus. This is an antibiotic-resistant version of the bacteria that causes styes, more commonly known as the hospital superbug MRSA. The potion killed 90 per cent of the bacteria. Vancomycin, the antibiotic generally used for MRSA, killed about the same proportion when it was added to the skin scraps.

A loathsome slime

Unexpectedly, the ingredients had little effect unless they were all brought together. “The big challenge is trying to find out why that combination works,” says Steve Diggle, another of the researchers. Do the components work in synergy or do they trigger the formation of new potent compounds?

Using exactly the right method also seems to be crucial, says Harrison, as another group tried to recreate the remedy in 2005 and found that their potion failed to kill bacteria grown in a dish. “With the nine-day waiting period, the preparation turned into a kind of loathsome, odorous slime,” says Michael Drout of Wheaton College in Norton, Massachusetts.

If the 9th Century recipe does lead to new drugs, they might be useful against MRSA skin infections such as those that cause foot ulcers in people with diabetes. “These are usually antibiotic-resistant,” says Diggle. However, he doesn’t recommend people try this at home.

It wouldn’t be the first modern drug to be derived from ancient manuscripts – the widely used antimalarial drug artemisinin was discovered by scouring historical Chinese medical texts.

Harrison is due to present the research at the Society for General Microbiology conference in Birmingham, UK, this week.


Comments? Good, or bad?

Or both?

Bioengineers develop tool for reprogramming genetic code

3 hours ago by Bjorn Carey
Bioengineers develop tool for reprogramming genetic code
Stanford bioengineers have developed a new tool that allows them to preferentially activate or deactivate genes in living cells. Credit: vitstudio/Shutterstock
Biology relies upon the precise activation of specific genes to work properly. If that sequence gets out of whack, or one gene turns on only partially, the outcome can often lead to a disease.

Now, bioengineers at Stanford and other universities have developed a sort of programmable genetic code that allows them to preferentially activate or deactivate genes in living cells. The work is published in the current issue of Cell, and could help usher in a new generation of gene therapies.

The technique is an adaptation of CRISPR, itself a relatively new genetic tool that makes use of a natural defense mechanism that bacteria evolved over millions of years to slice up infectious virus DNA.

Standard CRISPR consists of two components: a short RNA that matches a particular spot in the genome, and a protein called Cas9 that snips the DNA in that location. For the purposes of gene editing, scientists can control where the protein snips the genome, insert a new gene into the cut and patch it back together.

Inserting new , however, is just one way to influence how the genome is expressed. Another involves telling the cell how much or how little to activate a particular gene, thus controlling how much protein a cell produces from that gene and altering its behavior.

It’s this action that Lei Stanley Qi, an assistant professor of bioengineering and of chemical and systems biology at Stanford, and his colleagues aim to manipulate.

Influencing the genome

In the new work, the researchers describe how they have designed the CRISPR molecule to include a second piece of information on the RNA, instructing the molecule to either increase (upregulate) or decrease (downregulate) a target gene’s activity, or turn it on/off entirely.

Additionally, they designed it so that it could affect two different genes at once. In a cell, the order or degree in which are activated can produce different metabolic products.

“It’s like driving a car. You control the wheel to control direction, and the engine to control the speed, and how you balance the two determines how the car moves,” Qi said. “We can do the same thing in the cell by up- or downregulating genes, and produce different outcomes.”

As a proof of principle, the scientists used the technique to take control of a yeast metabolic pathway, turning genes on and off in various orders to produce four different end products. They then tested it on two mammalian genes that are important in cell mobility, and were able to control the cell’s direction and how fast it moved.


Future therapies

The ability to control genes is an attractive approach in designing genetic therapies for complex diseases that involve multiple genes, Qi said, and the new system may overcome several of the challenges of existing experimental therapies.

“Our technique allows us to directly control multiple specific and pathways in the genome without expressing new transgenes or uncontrolled behaviors, such as producing too much of a protein, or doing so in the wrong cells,” Qi said. “We could eventually synthesize tens of thousands of RNA molecules to control the genome over a whole organism.”

Next, Qi plans to test the technique in mice and refine the delivery method. Currently the scientists use a virus to insert the molecule into a cell, but he would eventually like to simply inject the molecules into an organism’s blood.

“That is what is so exciting about working at Stanford, because the School of Medicine’s immunology group is just around the corner, and working with them will help us address how to do this without triggering an immune response,” said Qi, who is a member of the interdisciplinary Stanford ChEM-H institute. “I’m optimistic because everything about this system comes naturally from , and should be compatible with any organism.”

Explore further: ‘CRISPR’ science: Newer genome editing tool shows promise in engineering human stem cells


Over the past four to five days I have discovered (both through experimentation and by healing animal patients) some very important medical principles which make the successful treatment of certain kinds of injuries and diseases much easier and much more effective. Also these principles make it far less likely that any form of treatment will in any way promote infection, interfere with the healing process, produce malignant counter or side effects, cause relapse, slow recovery, or prevent full recovery. Methods of the application of these principles vary according to the specific conditions surrounding the patient (age, general state of health, weight, etc.) and the individual nature of the case itself but the principles are valid in and of themselves.

I say discover, actually I have rediscovered (for I knew most of these principles already but either did not practice them fully or in the necessary manner or did not until recently realize their true import) or refined the principles I’m going to name, and I’m also sure the ancients and many medieval doctors knew them as well.

Additionally I should add the caveat that some of these principals are really for medical applications devoid of access to modern medical facilities and sometimes due to the fact of the lack of proper medicines – either because the patient and doctor/medic are isolated and cannot reach such facilities, because such facilities are not available in a given area, or because the patient lies on the borderline between being able to treat themselves or at home and needing to be hospitalized, but the injury or illness has not quite yet progressed to the point of an emergency hospitalization.

All of these Principles are going into my Book of Medicine as currently defined below, however as I improve upon my techniques and make further discoveries I will refine these definitions as necessary. Also I have a couple of ideas regarding inventions to best apply some of these principles but I’ll discuss those inventions at a later date after I’ve had a chance to work upon them.
1 THE PRINCIPLE OF HIBERNATION – The patient should be encouraged to or force himself to go into a state of self-induced hibernation or a coma-like state (even if this state must persist for many hours or even days or weeks) until the patent has reached the state that a sufficient point of verifiable recovery has been achieved or there are definite signs of self-sustaining improvement. The only treatment that should be administered or self-administered during this hibernation state should be small amounts of water with nutrients and electrolytes (liquid metaergogenics).

2 THE PRINCIPLE OF REVERSE APPLICATION – If the patient is unable or unwilling to eat then all necessary and beneficial nutrients and electrolytes should be introduced through liquids and via liquid consumption. If the patient is unwilling to drink then all necessary and beneficial nutrients and electrolytes should be introduced through whatever food is consumed and the food should be soaked in beneficial liquids and water and moisturized or reduced to a semi-liquid paste. These two principles are especially good and useful in cases where it is not possible to administer an IV .

3 THE PRINCIPLE OF APPLIED STASIS OR NON-INTERFERENCE – There are times when a patient has received a severe, traumatic, or at least serious injury or illness, and aside from keeping the patient warm and clean no attempt should be made to treat the patient at all other than the periodic administering of small amounts of food and/or drink (see principle of Reverse Application and the principle of Fasting) and instead they should encouraged to rest and to sleep (see principle of Hibernation). Only after a patient shows signs of the recovery of strength and of a tendency to recover should the patient be treated in a more normal manner to speed recovery.

4 THE PRINCIPLE OF FASTING – In certain situations the patient should not be fed at all but should undergo a period of fasting to best facilitate healing. Break the fast when signs of recovery become obvious or if the patient shows signs of weakness or harmful weight loss. Liquid intake should be maintained as normal or increased as necessary.

5. THE PRINCIPLE OF WOUND HOMEOSTASIS – Sometimes a wound (or even a state of illness) is too moist and must be drained, dried, and caused to remain dry (in a general sense, all biological health depends to some degree upon moisture) so as the suppress or prevent serious forms of infection (gangrene, etc.). Sometimes a wound (or even a state of illness) is too dry and requires the introduction of sterile yet beneficial forms of moisture and nutrients introduced through the medium of that moisture. Each particular case will vary according to the circumstances but if there are indications that the injury, wound, or disease state is too moist, then drying methods must be employed, and if there are indications that the injury, wound, or disease state is too dry then moisture must be applied. Then intent is to reach a state of patient homeostasis in which the patient can achieve and remain in an ongoing condition of optimal healing and recovery.

6. THE PRINCIPLE OF SHADOW (OR UNFELT OR UNKNOWN) TREATMENT APPLICATION – I will discuss this principle later after I have had more time to experiment. Initial indications show it to be very effective but the initial methods of application could be much improved I think. This is a new principle to me.


First contracting human muscle grown in laboratory

21 hours ago by Ken Kingery
First contracting human muscle grown in laboratory
A microscopic view of lab-grown human muscle bundles stained to show patterns made by basic muscle units and their associated proteins (red), which are a hallmark of human muscle. Credit: Nenad Bursac, Duke University
In a laboratory first, Duke researchers have grown human skeletal muscle that contracts and responds just like native tissue to external stimuli such as electrical pulses, biochemical signals and pharmaceuticals.

Build and Run Simulation Apps with COMSOL Server

The lab-grown tissue should soon allow researchers to test new drugs and study diseases in functioning outside of the .

The study was led by Nenad Bursac, associate professor of biomedical engineering at Duke University, and Lauran Madden, a postdoctoral researcher in Bursac’s laboratory. It appears January 13 in the open-access journal eLife

“The beauty of this work is that it can serve as a test bed for clinical trials in a dish,” said Bursac. “We are working to test drugs’ efficacy and safety without jeopardizing a patient’s health and also to reproduce the functional and of diseases—especially rare ones and those that make taking difficult.”

Bursac and Madden started with a small sample of human cells that had already progressed beyond stem cells but hadn’t yet become . They expanded these “myogenic precursors” by more than a 1000-fold, and then put them into a supportive, 3D scaffolding filled with a nourishing gel that allowed them to form aligned and functioning .

“We have a lot of experience making bioartifical muscles from animal cells in the laboratory, and it still took us a year of adjusting variables like cell and gel density and optimizing the culture matrix and media to make this work with human muscle cells,” said Madden.


Madden subjected the new muscle to a barrage of tests to determine how closely it resembled native tissue inside a human body. She found that the muscles robustly contracted in response to electrical stimuli—a first for human muscle grown in a laboratory. She also showed that the signaling pathways allowing nerves to activate the muscle were intact and functional.

To see if the muscle could be used as a proxy for medical tests, Bursac and Madden studied its response to a variety of drugs, including statins used to lower cholesterol and clenbuterol, a drug known to be used off-label as a performance enhancer for athletes.

The effects of the drugs matched those seen in human patients. The statins had a dose-dependent response, causing abnormal fat accumulation at high concentrations. Clenbuterol showed a narrow beneficial window for increased contraction. Both of these effects have been documented in humans. Clenbuterol does not harm muscle tissue in rodents at those doses, showing the lab-grown muscle was giving a truly human response.

“One of our goals is to use this method to provide personalized medicine to patients,” said Bursac. “We can take a biopsy from each patient, grow many new muscles to use as test samples and experiment to see which drugs would work best for each person.”

First contracting human muscle grown in laboratory
Two lab-grown human muscle bundles stretched in a rectangular frame submerged in media. Credit: Nenad Bursac, Duke University

This goal may not be far away; Bursac is already working on a study with clinicians at Duke Medicine—including Dwight Koeberl, associate professor of pediatrics—to try to correlate efficacy of drugs in patients with the effects on lab-grown muscles. Bursac’s group is also trying to grow contracting human muscles using induced pluripotent instead of biopsied cells.

“There are a some diseases, like Duchenne Muscular Dystrophy for example, that make taking biopsies difficult,” said Bursac. “If we could grow working, testable muscles from induced , we could take one skin or blood sample and never have to bother the patient again.”

Other investigators involved in this study include George Truskey, the R. Eugene and Susie E. Goodson Professor of Biomedical Engineering and senior associate dean for research for the Pratt School of Engineering, and William Krauss, professor of , medicine and nursing at Duke University.

The research was supported by NIH Grants R01AR055226 and R01AR065873 from the National Institute of Arthritis and Musculoskeletal and Skin Disease and UH2TR000505 from the NIH Common Fund for the Microphysiological Systems Initiative.

Explore further: Self-healing engineered muscle grown in the laboratory

More information: “Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs,” Lauran Madden, Mark Juhas, William E Kraus, George A Truskey, Nenad Bursac. eLife, Jan. 13, 2015. DOI: 10.7554/eLife.04885